AKT1 and cancer: Lidocaine may exert its anti-cancer effects indirectly by inhibiting PI3K/Akt, which, in turn, affects Hippo signaling, while linolenic acid has been shown to maintain YAP levels in the cytoplasm and directly inhibit cancer cell growth through the Hippo pathway.